LitigationUSA
USA Litigation Update Puts AstraZeneca and Soliris Strategy in Focus
IIPLA reviews the litigation implications of Litigation, AstraZeneca, Soliris, with practical notes for USA IP teams monitoring risk, enforcement, licensing, and portfolio strategy.
Monday, November 16, 2026